Michael Gottlieb

Chairman of the Board of Directors

Michael Gottlieb is the Chairman of the Board of Directors at Domain Therapeutics. He has vast international experience in leading biopharmaceutical companies, and now Michael drives Domain’s strategic direction to become a global leader in immuno-oncology, unlocking new possibilities in GPCR targeted cancer immunotherapies.

Michael has a strong background in governance, board leadership, strategic development, innovation and finance in public and private operations supported by his CPA, CA designation. He is currently the President and Chief Executive Officer of RENOGENYX. Previously, Michael was the Chief Commercial Officer of POINT Biopharma (PNT:NASDAQ), leading global commercial operations and market strategy. Michael also held several leadership roles at Sanofi Genzyme Canada, overseeing a diverse product portfolio in immunology, neurology, oncology and rare diseases. Michael holds a Bachelor of Science in biology from Western University and a combined master’s degree in business and accounting from the University of Toronto.